Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 161

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Effect of a new synbiotic mixture on atopic dermatitis in infants: a randomized‐controlled trial

Van Der Aa, L. B., Heymans, H. S., Van Aalderen, W. M., Sillevis Smitt, J. H., Knol, J., Ben Amor, K., Goossens, D. A., Sprikkelman, A. B., the Synbad Study Group · 2010 · Clinical & Experimental Allergy

Abstract

Summary: Background Clinical trials investigating the therapeutic effect of probiotics on atopic dermatitis (AD) show inconsistent results. Better results can possibly be achieved by combining probiotics with prebiotics, i.e. synbiotics. Objective To investigate the therapeutic effect of a synbiotic mixture on the severity of AD in infants. Methods In a double‐blind, placebo‐controlled multi‐centre trial, 90 infants with AD [SCORing Atopic Dermatitis (SCORAD) score 15], aged <7 months and exclusively formula fed, were randomly assigned to receive either an extensively hydrolysed formula with Bifidobacterium breve M‐16V and a galacto‐/fructooligosaccharide mixture (Immunofortis®), or the same formula without synbiotics for 12 weeks. The primary outcome was severity of AD, assessed using the SCORAD index. A secondary outcome measure was intestinal microbiota composition. Results There was no difference in SCORAD score improvement between the synbiotic and the placebo group. The synbiotic group did have a significantly higher percentage of bifidobacteria (54.7% vs. 30.1%, P<0.001) and significantly lower percentages of Clostridium lituseburense/Clostridium histolyticum (0.5 vs. 1.8, P=0.02) and Eubacterium rectale/Clostridium coccoides (7.5 vs. 38.1, P<0.001) after intervention than the placebo group. In the subgroup of infants with IgE‐associated AD (n=48), SCORAD score improvement was significantly greater in the synbiotic than in the placebo group at week 12 (−18.1 vs. −13.5 points, P=0.04). Conclusions This synbiotic mixture does not have a beneficial effect on AD severity in infants, although it does successfully modulate their intestinal microbiota. Further randomized‐controlled trials should explore a possible beneficial effect in IgE‐associated AD. Cite this as: L. B. van der Aa, H. S. Heymans, W. M. van Aalderen, J. H. Sillevis Smitt, J. Knol, K. Ben Amor, D. A. Goossens, A. B. Sprikkelman and the Synbad Study Group, Clinical & Experimental Allergy, 2010 (40) 795–804.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2222.2010.03465.x

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 161

Metadata

Authors
Van Der Aa, L. B., Heymans, H. S., Van Aalderen, W. M., Sillevis Smitt, J. H., Knol, J., Ben Amor, K., Goossens, D. A., Sprikkelman, A. B., & the Synbad Study Group
Venue
Clinical & Experimental Allergy
Publisher
Wiley
Published
2010-04-19
Volume
40
Issue
5
Pages
795-804
ISSN
  • 0954-7894 (ISSN-L)
  • 1365-2222
OpenAlex
W2107522056
Cited by
161
References
1
FWCI
20.81
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of a new synbiotic mixture on atopic dermatitis in infants: a randomized‐controlled trial. https://app.cochat.ai/papers/10.1111/j.1365-2222.2010.03465.x
The paper
Van Der Aa, L. B., Heymans, H. S., Van Aalderen, W. M., Sillevis Smitt, J. H., Knol, J., Ben Amor, K., Goossens, D. A., Sprikkelman, A. B., & the Synbad Study Group. (2010). Effect of a new synbiotic mixture on atopic dermatitis in infants: a randomized‐controlled trial. Clinical & Experimental Allergy. https://doi.org/10.1111/j.1365-2222.2010.03465.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.